AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.

AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q31158130

about

Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysis Systematic review: Preventive and therapeutic applications of metformin in liver disease Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.Garlic Oil Suppressed Nitrosodiethylamine-Induced Hepatocarcinoma in Rats by Inhibiting PI3K-AKT-NF-κB Pathway.Targeting AMPK for cancer prevention and treatment.Prognostic significance of AMPK in human malignancies: A meta-analysis.Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells.Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway.Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway.AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.Fatsioside A‑induced apoptotic death of HepG2 cells requires activation of AMP‑activated protein kinase.Down-regulation of adenosine monophosphate-activated protein kinase activity: A driver of cancer.Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids.

P2860

Q27306002-ECD3F3C1-0541-44BA-9C5D-C73C1DF345C8 Q28085535-D36617EE-5A1C-4D8D-9A56-A2D741091444 Q30395557-E5C094EB-12BC-4F4C-ACB4-030A6FE2C9EC Q35447135-3C917DE3-32FD-4371-8223-0E9886048B03 Q35632717-7AC53B12-E4D1-4EE2-B240-AE4F809B488B Q35781311-80CC689B-4748-4A64-8EAF-565A0E9F41F3 Q36157437-9DE47FDB-B65D-4F2F-AFB9-F57D5F5FEB8E Q36418806-B98FA933-5416-4418-AE90-E96A83929887 Q36788544-DB5FB856-ACD5-4139-A2E3-9DADB53DCA2A Q37530765-45833AA3-4F9D-4A03-9180-8BDE40710CA1 Q37697040-73445930-CB41-41A1-92B2-D4BCEA174D8C Q37706711-9A3FA4BD-7DBF-4859-9C5C-2D3217D94501 Q38792676-2AFD9570-5143-4E63-B51F-2E9461056292 Q38807302-D6A0EB8F-33B7-42C3-BC50-57719E3B7A39 Q38845499-4D299597-3C45-4F5E-9696-5423CEE55973 Q39222558-59E7F43C-0A74-48DF-836C-5039CED91DEA Q41194460-0488CFE2-D863-44EF-967E-36253693EF3D Q47547628-8F5EBC55-E43B-4308-959C-609CF59AACD4 Q51451285-90268D53-0BA3-44D3-BF6B-0B4A8BB8C736

P2860

AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q31158130

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

AMP-activated protein kinase s ...... n of hepatocellular carcinoma.

@ast

AMP-activated protein kinase s ...... n of hepatocellular carcinoma.

@en

type

label

AMP-activated protein kinase s ...... n of hepatocellular carcinoma.

@ast

AMP-activated protein kinase s ...... n of hepatocellular carcinoma.

@en

prefLabel

AMP-activated protein kinase s ...... n of hepatocellular carcinoma.

@ast

AMP-activated protein kinase s ...... n of hepatocellular carcinoma.

@en

P1433

Q31158130-4C740BC6-7D14-43BB-AB5B-BF928C3102C3

P1476

Q31158130-76A76C9E-FF13-4357-AA2B-BA4D786298CF

P2093

Q31158130-03C3F4FE-A007-4382-98DF-12F11496B968

Q31158130-2A7244F0-A29F-4EE5-92EE-9E48329A7CEF

Q31158130-2F9157BA-2A3E-485E-95BC-38897BC8D1DE

Q31158130-3951305C-42FE-4B98-8FDE-4593883C1A87

Q31158130-46D510CE-7FA0-45E6-B313-331AC4160A8C

Q31158130-5C82B2AA-1814-4909-B8C8-111AF8C81374

Q31158130-9262A3F4-B4AF-4E8C-9BBA-68DB99385C74

Q31158130-A0253947-FCFE-4F7E-8830-C7AB0CF905F5

Q31158130-B4E7035C-9D1D-4C80-8DC9-6C3FF7B3C66C

Q31158130-C0D2C268-8B2B-40D1-AA5A-C30520C07168

P2860

Q31158130-01ADE1A4-184A-4C91-ABD2-7913505EE411

Q31158130-0A8CB259-CB17-4FAE-8D84-9E64E4023A72

Q31158130-18BF7CE7-D362-41D8-852E-74D284DB34BD

Q31158130-1C7F8C54-C460-44C4-BA40-10F228548044

Q31158130-2DB30C8A-5E90-441F-9EA1-A81844A3C813

Q31158130-3F99CB55-BC12-4043-8E69-6A5EEFC5B5BB

Q31158130-40AEEF16-951C-4445-8022-C998524B671B

Q31158130-486D1629-F762-451E-AB39-94FF86573F96

Q31158130-4C065CFC-6545-4B6C-9242-53E1BAED7344

Q31158130-4C1197C9-0A7B-4F8A-810E-227B3FE8BE9D

P304

Q31158130-F9219B7C-7132-47C1-8B22-06A3E812E2D3

P31

Q31158130-25E51218-D838-4AC8-BA7A-6F6F6B395311

P356

Q31158130-17161015-3D49-4083-A9A2-838E2606F81B

P407

Q31158130-328F780E-E9CE-44A5-87FC-B91E9BFFFDF0

P433

Q31158130-0B7FB3E8-7538-4A3F-BF95-392ED729DD3E

P478

Q31158130-7E1CAD91-9952-47BB-B707-08502DBE3961

P577

Q31158130-21E54228-6272-47FE-A165-ABCA707F4FDF

P5875

Q31158130-606512E1-AEA2-410F-A902-DA0258EEB7C4

P698

Q31158130-E827E697-EDDE-446F-8E73-F13F086A60F1

P932

Q31158130-D57EBD3C-10FF-427C-80FF-D4B0F8D5C8F6

P356

JOURNAL.PONE.0093256

P1433

P1476

AMP-activated protein kinase s ...... n of hepatocellular carcinoma.

@en

P2093

Jidong Cheng

http://www.w3.org/2001/XMLSchema#string

Jiexiong Huang

http://www.w3.org/2001/XMLSchema#string

Qingjia Wang

http://www.w3.org/2001/XMLSchema#string

Tetsuya Yamamoto

http://www.w3.org/2001/XMLSchema#string

Tianliang Huang

http://www.w3.org/2001/XMLSchema#string

Weijie Cheng

http://www.w3.org/2001/XMLSchema#string

Weisheng Chen

http://www.w3.org/2001/XMLSchema#string

Xiaojun Tan

http://www.w3.org/2001/XMLSchema#string

Xubin Jing

http://www.w3.org/2001/XMLSchema#string

Yongneng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

At the crossroads: AMP-activated kinase and the LKB1 tumor suppressor link cell proliferation to metabolic regulation

Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung

Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis

Metformin and reduced risk of cancer in diabetic patients

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis

Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest

P304

e93256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0093256

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261443982

http://www.w3.org/2001/XMLSchema#string

P698

24709998

http://www.w3.org/2001/XMLSchema#string

P932

3977828

http://www.w3.org/2001/XMLSchema#string